Skip to content

Insider · CIK 0001616230

Adrian Senderowicz

director

Files at PBYI (PUMA BIOTECHNOLOGY, INC.). First filing Jun 17, 2025, latest Jun 17, 2025.

Adrian Senderowicz files SEC Form 4 as director at PBYI (PUMA BIOTECHNOLOGY, INC.). Since Jun 17, 2025, Adrian Senderowicz has reported 0 open-market buys worth $0 and 1 open-market sell worth $92k, the latest filed on Jun 17, 2025.

A track record needs three past buys with six months of prices behind them; Adrian Senderowicz has 0, so none is measured yet.

The newest scored trade: sold $92k of PBYI on Jun 13, 2025, filed Jun 17, 2025, scored 39 (weak), under a 10b5-1 plan.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $92k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

PBYI: PUMA BIOTECHNOLOGY, INC.

PBYIOct 9, 2026 · close 10.29

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
39Weak
PBYIsell 610b5-1
PUMA BIOTECHNOLOGY, INC.
$92k
27,000 shares
-50%+38% from low-10% from high

Planned sales

Form 144 notices this insider filed before selling restricted or control stock, newest first.

FiledCompanySharesValueSale datePast 3 months
Jun 13, 2025 PBYI
PUMA BIOTECHNOLOGY, INC.
27,000
0.05% of outstanding
$92kJun 13, 2025none

Transactions

Every row this insider has filed, 2 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jun 13, 2025PBYI
PUMA BIOTECHNOLOGY, INC.
SOpen-market sale
Common Stock10b5-1
-27,000$3.40$92k27,000Jun 17, 2025
Jun 11, 2025PBYI
PUMA BIOTECHNOLOGY, INC.
AGrant or award
Common Stock
+27,000$0.00$054,000Jun 13, 2025

Questions about Adrian Senderowicz

Answered from the filings on this page, as of the latest one.

Is Adrian Senderowicz buying or selling?

Not in the last 12 months. Adrian Senderowicz's latest open-market trade on SEC Form 4 was sold $92k of PBYI on Jun 13, 2025.

How did Adrian Senderowicz's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Adrian Senderowicz has 0.

Where does Adrian Senderowicz file Form 4?

Adrian Senderowicz has filed Form 4 at PBYI (PUMA BIOTECHNOLOGY, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Adrian Senderowicz: insider trades and track record | InsiderTell